Jupiter Life Line Hospitals Q2 FY27 Results: Consolidated Net Profit ₹56.36 Crore on Total Income of ₹467 Crore
Earnings
Healthcare services
Blacklitt Research4 min read
Jupiter Life Line Hospitals (NSE: JLHL) reported consolidated total income of ₹467.04 crore and net profit of ₹56.36 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹371.49 crore and net profit of ₹51.45 crore, it said in a filing on 23 Oct 2026.
Key highlights
Consolidated
Including its subsidiaries
Total income: ₹467.04 crore, up 15.3% YoY and 10.8% QoQ
Net profit: ₹56.36 crore, down 1.9% YoY and up 50.2% QoQ
EPS: ₹1.72 basic, against ₹1.75 a year earlier
Finance costs: ₹13.83 crore, 3.0% of total income
Standalone
The company on its own, without its subsidiaries
Total income: ₹371.49 crore, up 13.6% YoY and 9.5% QoQ
Net profit: ₹51.45 crore, down 5.8% YoY and up 38.4% QoQ
EPS: ₹1.57 basic, against ₹1.67 a year earlier
Other income: ₹6.89 crore, down 39.1% YoY
Summary
Consolidated ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
467.04
404.90
+15.3%
421.57
+10.8%
Revenue from operations
456.50
393.63
+16.0%
410.98
+11.1%
Other income
10.54
11.27
-6.5%
10.59
-0.4%
56.36
57.48
-1.9%
37.51
+50.2%
Profit before tax
75.08
74.22
+1.2%
50.55
+48.5%
Finance costs
13.83
n/a
n/a
12.86
+7.5%
Depreciation
28.48
n/a
n/a
26.44
+7.7%
Tax expense
18.73
16.75
+11.8%
13.04
+43.6%
Net profit margin
12.07%
14.20%
-2.13 pp
8.90%
+3.17 pp
EPS, basic (₹)
1.72
1.75
-1.7%
1.14
+50.9%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated total income grew faster than net profit this quarter. Revenue from operations rose 16.0% YoY to ₹456.50 crore, while other income fell 6.5% to ₹10.54 crore. Net profit fell 1.9% to ₹56.36 crore over the same period, while profit before tax rose 1.2% to ₹75.08 crore.
The gap between profit before tax and net profit is the tax line: tax expense rose 11.8% to ₹18.73 crore, which is 24.9% of profit before tax. The filing sets out the figures but does not give a reason for the change in the tax charge.
Finance costs of ₹13.83 crore are 3.0% of total income. The year-ago quarter's finance costs and depreciation could not be reliably matched in the statement, so no year-on-year comparison is given for those lines.
Against the previous quarter, net profit rose 50.2% to ₹56.36 crore on total income up 10.8%. The quarter-on-quarter comparison is the larger of the two moves; the year-on-year figures are close to flat on profit.
Standalone ₹ crore
Particulars
Q2 FY27
Q2 FY26
YoY
Q1 FY27
QoQ
371.49
327.13
+13.6%
339.13
+9.5%
Revenue from operations
364.60
315.82
+15.4%
328.49
+11.0%
Other income
6.89
11.31
-39.1%
10.64
-35.2%
51.45
54.60
-5.8%
37.19
+38.4%
Profit before tax
68.51
70.48
-2.8%
50.11
+36.7%
Finance costs
9.04
16.68
-45.8%
8.12
+11.4%
Depreciation
23.46
49.78
-52.9%
21.57
+8.8%
Tax expense
17.05
15.88
+7.4%
12.92
+32.0%
Net profit margin
13.85%
16.69%
-2.84 pp
10.97%
+2.88 pp
EPS, basic (₹)
1.57
1.67
-6.0%
1.13
+38.9%
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit fell 5.8% YoY to ₹51.45 crore, more than profit before tax, which fell 2.8% to ₹68.51 crore. Tax expense rose 7.4% to ₹17.05 crore, equal to 24.9% of profit before tax.
Depreciation fell 52.9% YoY to ₹23.46 crore, from ₹49.78 crore a year earlier. The filing does not explain the change, and the year-ago figure is the base against which the decline is measured.
Other income fell 39.1% to ₹6.89 crore and is 1.9% of total income. Standalone revenue from operations rose 15.4% YoY to ₹364.60 crore.
Consolidated net profit of ₹56.36 crore is ₹4.91 crore higher than standalone net profit of ₹51.45 crore, and consolidated total income is ₹95.55 crore higher than standalone total income.
The filing also reports a ₹150 crore land purchase for a site at Bibvewadi, Pune, on which the company's South Pune hospital project is under development. The land was previously held under a lease arrangement. The company says the acquisition is not a related party transaction.
The filing reports a share sub-division of each ₹10 equity share into five ₹2 shares, with record date 24 Jul 2026. The EPS figures are stated after that sub-division. Standalone and consolidated results include exceptional gratuity charges of ₹43.89 million and ₹48.87 million respectively, recognised for the year ended 31 Mar 2026 under the New Labour Codes. Auditors issued unmodified limited review reports on both sets of results.
Inference
The board approved incorporation of Holitti Private Limited, a wholly owned subsidiary for healthcare services, with paid-up capital of ₹1 lakh. The company says the subsidiary will be incorporated, and it is not stated when that will happen or how it will be funded beyond the initial capital.
The ₹150 crore land consideration is set against a company whose consolidated net profit for the quarter was ₹56.36 crore. The filing does not state the payment schedule or the funding source for the purchase.
The timing of that sanction is not stated, and the effect of the merger on the figures is not known.
Create a free account to read the rest of this article and the analysis that follows.
By continuing you agree to our Terms and Privacy Policy, and to receive updates from Blacklitt by email. You can unsubscribe anytime.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
JLHLJupiter Life Line Hospitals Ltd.
